
Gabriel Lopez-Peña ChM, FRCS
@gabrielglp
Vascular Surgeon trained at @incmnszmx 🇲🇽 - Vascular Surgery CRF/PhD student Imperial College London 🇬🇧- opinions are my own
ID: 278856585
08-04-2011 03:18:09
1,1K Tweet
245 Followers
3,3K Following


BASIL2 RCT paper now available on The Lancet Endovascular strategy superior for BTK lesions in terms of amputation free survival. thelancet.com/journals/lance…

Ranovelo Ruben Ramos Omar Ramírez Saavedra elizondomd Gabriel Lopez-Peña ChM, FRCS Arriaga Vascular Toño Muñoa Rebeca Reachi Lugo Fuera NarcoPresidente Guillermo Escobar🩸 Manuel Garcia-Toca AudibleBleeding Rodrigo Garza-Herrera Mauricio Gonzalez-Urquijo Necio L Dr. Angiocito 👑🤴 Sociedad Española de Angiología y Cirugía Vascular DR.SERRANO


BASIL-2 discussion #CLTI #VascularSurgery SMACVE Necio Lizola MD Santiago Mier y Terán LuisH Carlos A Hinojosa enjoy. Thank you 🙏🏻🙏🏻 Athanasios Saratzis open.spotify.com/episode/4FTPOB…



Congratulations to the prize winners from the BSET Annual Meeting 2023: Anna Louise Pouncey Imperial College London Vascular Surgery : Aortic Prize Gabriel Lopez-Pena Research at Leicester's Hospitals : Peripheral Prize Harry Cavenagh Norfolk and Norwich University Hospitals : Poster Prize


Congratulations to vascular surgeon Gabriel Lopez-Peña ChM, FRCS for winning the #PAD prize from BSET! 🏆 On his recent success, Gabriel said: “I am really grateful and happy for the opportunity Athanasios Saratzis gave me. I look forward to continuing #research in #vascular surgery.”



Biomimetic Stents for Infra-inguinal Peripheral Arterial Disease: Systematic Review and Meta-Analysis - European Journal of Vascular and Endovascular Surgery Biomimetic stents, great job! SJ Messeder Athanasios Saratzis ejves.com/article/S1078-…

Del INCMNSZ para el mundo. Carlos A Hinojosa #PVI2023 Paris Vascular Insights Course #VascularSurgery Santiago Mier y Terán LuisH






EVOCC trial presented by Gabriel Lopez-Peña ChM, FRCS INCMNSZ. Changing practice with meaningful data. Excellent work Athanasios Saratzis and team!


The UK’s first major study into treatment options for uncomplicated type B aortic dissection is now live! We’re proud that our Patient & Public Panel helped shape the EARNEST trial, keeping the voices of those affected at the core of this vital research. aorticdissectioncharitabletrust.org/earnest-trial/
